Novartis plans to invest $23 billion in U.S. plants as Trump renews drug tariff threats
Swiss drugmaker Novartis said it plans to spend $23 billion to build and expand 10 facilities in the U.S. as it grapples with Trump's threats of drug tariffs.
You are not logged in so some information on this page has been withheld. To see more, please log in.